Miloš Danilović

2PUBLICATIONS
4CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 14, 2023
Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic.

Stefan Todorović, Slobodan Vojinović, Dejan Savić

Pageof 1